Induced expression of MyoD, myogenin and desmin during myoblast differentiation in embryonic mouse tongue development

Archives of Oral Biology

Volumn 43, Issue 5, 1998, Pages 407-416

  Yamane, A ^a   Takahashi, K ^b   Mayo, M ^c   Vo, H ^c   Shum, L ^b   Zeichner David, M ^c   Slavkin, H C ^b  

^a TSURUMI UNIVERSITY   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Competitive RT PCR; Desmin; Mandibular organ culture; Mouse tongue; myf5; MyoD; Myogenesis; Myogenic regulatory factors; Myogenin; Serumless and chemically defined medium; TGF

Indexed keywords

DESMIN; MUSCLE PROTEIN; MYOD PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR, MYF-5; MYOGENIC FACTOR, MYF-6; MYOGENIN; RNA; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLOGY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOLOGY; GENE EXPRESSION REGULATION; MANDIBLE; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; ORGAN CULTURE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STATISTICAL ANALYSIS; TONGUE;

ANALYSIS OF VARIANCE; ANIMALS; CELL DIFFERENTIATION; CULTURE MEDIA, SERUM-FREE; DESMIN; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIC REGULATORY FACTOR 5; MYOGENIC REGULATORY FACTORS; MYOGENIN; ORGAN CULTURE TECHNIQUES; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RNA; SIGNAL TRANSDUCTION; TONGUE; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMALIA;

EID: 0032076678     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(98)00018-1     Document Type: Article

References (57)

1. Andrés V., Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132:1996;657-666.
2. Askanas V., Gallez-Hawkins G. Synergistic influence of polypeptide growth factors on cultured human muscle. Arch. Neurol. 42:1985;749-752.
3. Bennett A.M., Tonks N.K. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science. 278:1997;1288-1291.
4. Blachowski S., Motyl T., Orzechowski A., Grzelkowska K., Interewicz B. Comparison of metabolic effects of EGF, TGF-α and TGF-β1 in primary culture of fetal bovine myoblasts and rat L6 myoblasts. Int. J. Biochem. 25:1993;1571-1577.
5. Braun T., Arnold H-H. myf-5 and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO J. 15:1996;310-318.
6. Braun T., Arnold H-H. ES-cells carrying two inactivated myf-5 alleles form skeletal muscle cells: activation of an alternative myf-5-independent differentiation pathway. Dev. Biol. 164:1994;24-36.
7. Braun T., Rudnicki M.A., Arnold H-H., Jaenisch R. Targeted inactivation of the muscle regulatory gene myf-5 results in abnormal rib development and perinatal death. Cell. 71:1992;369-382.
8. Brennan T.J., Edmondson D.G., Li L., Olson E.N. Transforming growth factor β represses the actions of myogenin through a mechanism independent of DNA binding. Proc. Natl. Acad. Sci. USA. 88:1991;3822-3826.
9. Buckingham M. Making muscle in mammals. Trends Genet. 8:1992;144-149.
10. Buckingham M. Skeletal muscle development and the role of the myogenic regulatory factors. Biochem. Soc. Trans. 24:1996;506-509.
11. Buonanno A., Apone L., Morasso M.I., Beers R., Brenner H.R., Eftimie R. The MyoD family of myogenic factors is regulated by electrical activities: isolation and characterization of a mouse Myf-5 cDNA. Nucl. Acids Res. 20:1992;539-544.
12. Derynck R. The physiology of transforming growth factor-α Adv. Cancer Res. 58:1992;27-52.
13. Florini J.R., Ewton D.Z., Magri K.A., Mangiacapra F.J. IGFs and muscle differentiation. Adv. Exp. Med. Biol. 343:1994;319-326.
14. Florini J.R., Ewton D.Z., Roof S.L. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol. Endocrinol. 5:1991;718-724.
15. Hannon K., Smith I.C.K., Bales K.R., Santerre R.F. Temporal and quantitative analysis of myogenic regulatory and growth factor gene expression in the developing mouse embryo. Dev. Biol. 151:1992;137-144.
16. Hasty P., Bradley A., Morris J.H., Edmondson D.G., Venuti J.M., Olson E.N., Klein W.H. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature. 364:1993;501-506.
17. Hinterberger T.J., Sassoon D.A., Rhodes S.J., Konieczny S.F. Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development. Dev. Biol. 147:1991;144-156.
18. Kelvin D.J., Simard G., Connolly J.A. FGF and EGF act synergistically to induce proliferation in BC3H1 myoblasts. J. Cell. Physiol. 138:1989;267-272.
19. val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol. Cell. Biol. 15:1995;5205-5213.
20. Kuisk I.R., Li H., Tran D., Capetanaki Y. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis. Dev. Biol. 174:1996;1-13.
21. Lassar A.B., Skapek S.X., Bennett N. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawl. Curr. Opin. Cell Biol. 6:1994;788-794.
22. Li H., Capetanaki Y. Regulation of the mouse desmin gene: transactivation by MyoD, myogenin, MRF4 and Myf5. Nucl. Acids Res. 21:1993;335-343.
23. Li H., Choudhary S.K., Milner D.J., Munir M.I., Kuisk I.R., Capetanaki Y. Inhibition of desmin expression blocks myoblasts fusion and interferes with the myogenic regulators MyoD and Myogenin. J. Cell Biol. 124:1994;827-841.
24. Li Z., Marchand P., Humbert J., Babinet C., Paulin D. Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development. 117:1993;947-959.
25. Li Z., Paulin D. High level desmin expression depends on a muscle-specific enhancer. J. Biol. Chem. 266:1991;6562-6570.
26. Li L., Zhou J., James G., Heller-Harrison R., Czech M.P., Olson E.N. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell. 71:1992;1181-1194.
27. Lim R.W., Hauschka S.D. A rapid decrease in epidermal growth factor-binding capacity accompanies the terminal differentiation of mouse myoblasts in vitro. J. Cell Biol. 98:1984;739-747.
28. Lim R.W., Hauschka S.D. EGF responsiveness and receptor regulation in normal and differentiation-defective mouse myoblasts. Dev. Biol. 105:1984;48-58.
29. Ludolph D.C., Konieczny S.F. Transcription factor families: muscling in on the myogenic program. FASEB J. 9:1995;1595-1604.
30. Luetteke N.C., Lee D.C., Palmiter R.D., Brinster R.L., Sandgren E.P. Regulation of fat and muscle development by transforming growth factor α in transgenic mice and in cultured cells. Cell Growth Differ. 203:1993;203-213.
31. Luetteke N.C., Qiu T.H., Peiffer R.L., Oliver P., Smithies O., Lee D.C. TGF α deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 73:1993;263-278.
32. Mann G.B., Fowler K.J., Gabriel A., Nice E.C., Williams R.L., Dunn A.R. Mice with a null mutation of the TGFα genes have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell. 73:1993;249-261.
33. Martin J.F., Li L., Olson E.N. Repression of myogenin function by TGF-β1 is targeted at the basic helix-loop-helix motif and is independent of E2A products. J. Biol. Chem. 267:1992;10956-10960.
34. Mayo L.M., Bringas P. Jr, Santos V., Shum L., Slavkin H.C. Desmin expression during early mouse tongue morphogenesis. Int. J. Dev. Biol. 36:1992;255-263.
35. Miner J.H., Wold B. Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc. Natl. Acad. Sci. USA. 87:1990;1089-1093.
36. Nabeshima Y., Hanaoka K., Hayasaka M., Esumi E., Li S., Nonaka I., Nabeshima Y.I. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature. 364:1993;532-535.
37. Olson E.N. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154:1992;261-272.
38. Olson E.N., Klein W. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1994;1-8.
39. Olson E.N., Brennan T.J., Chakraborty T., Cheng T-C., Cserjesi P., Edmondson D., James G., Li L. Molecular control of myogenesis: antagonism between growth and differentiation. Mol. Cell. Biochem. 104:1991;7-13.
40. Ott M-O., Bober E., Lyons G., Arnold H., Buckingham M. Early expression of the myogenic regulatory gene, myf-5, in precursor cells of skeletal muscle in the mouse embryo. Development. 111:1991;1097-1107.
41. Patapoutian A., Yoon J.K., Miner J.H., Wang S., Stark K., Wold B. Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. Development. 121:1995;3347-3358.
42. Rawls A., Olson E.N. MyoD meets its maker. Cell. 89:1997;5-8.
43. Rudnicki M.A., Braun T., Hinuma S., Jaenisch R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell. 71:1992;383-390.
44. Rudnicki M.A., Jaenisch R. The myoD family of transcription factors and skeletal myogenesis. Bioessays. 17:1995;203-209.
45. Rudnicki M.A., Schnegelsberg P.N.J., Stead R.H., Braun T., Arnold H-H., Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell. 75:1993;1351-1359.
46. Sassoon D., Lyons G., Wright W.E., Lin V., Lassar A., Weintraub H., Buckingham M. Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature. 341:1989;303-307.
47. Schaart G., Viebahn C., Langmann W., Ramaekers F. Desmin and titlin expression in early postimplantation mouse embryo. Development. 107:1989;585-596.
48. Siebert P.D., Larrick J.W. Competitive PCR. Nature. 359:1992;557-558.
49. Siebert P.D., Larrick J.W. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques. 14:1993;244-249.
50. Shum L., Sakakura Y., Bringas P. Jr, Luo W., Snead M.L., Mayo M., Crohin C., Millar S., Werb Z., Buckley S., Hall F.L., Warburton D., Slavkin H.C. EGF abrogation-induced fusilli-form dysmorphogenesis of Meckel's cartilage during embryonic mouse mandibular morphogenesis in vitro. Development. 118:1993;903-917.
51. Slavkin H.C., Bringas P. Jr, Sasano Y., Mayo M. Early embryonic mouse mandibular morphogenesis and cyodifferentiation in serumless, chemically defined medium: a model for studies of autocrine and/or paracrine regulatory factors. J. Craniofac. Genet. Dev. Biol. 9:1989;185-205.
52. Sokal, R.R., Rohlf, F.J., 1981. Biometry. The principles and practice of statistics in biological research, 2nd Edition. W.H. Freeman and Company, New York, pp. 208-270.
53. Theiler, K., 1972. The house mouse. Springer-Verlag, New York.
54. Venuti J.M., Cserjesi P. Molecular embryology of skeletal myogenesis. Curr. Top. Dev. Biol. 34:1996;169-206.
55. Weintraub H. The MyoD family and myogenesis: redundancy, networks and thresholds. Cell. 75:1993;1241-1244.
56. Yamane A., Mayo M.L., Bringas P. Jr, Chen L., Huynh M., Thai K., Shum L., Slavkin H.C. TGF-alpha, EGF and their cognate EGF receptor are co-expressed with desmin during embryonic, fetal and neonatal myogenesis in mouse tongue development. Dev. Dyn. 209:1997;353-366.
57. Zhao J., Araki N., Nishimoto S.K. Quantitation of matrix Gla protein mRNA by competitive polymerase chain reaction using glyceraldehyde-3-phosphate dehydrogenase as an internal control. Gene. 155:1995;159-165.